Clinical Trial Update: An Exploratory Study of Lurbinectedin With Radiotherapy in Locally-advanced SCLC After First-line Therapy [Phase 2]

View source ↗

Summary

An exploratory Phase 2 study of lurbinectedin combined with radiotherapy for locally-advanced small cell lung cancer after first-line therapy, currently not yet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Lurbinectedin (Zepzelca) (lurbinectedin)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Small Cell Lung Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING